Cancer Clinical Trials

Clinical research studies in Amarillo

BSA Health System’s Harrington Cancer Center offers clinical research trials as part of our commitment to treating cancer and increasing survivorship for patients in Amarillo, Texas. We offer a wide range of advanced clinical trial opportunities to patients who have been newly diagnosed, have advanced staged cancer, or those who have run out of standard of care options.

There are many benefits to participating in clinical trials. Clinical research studies may:

• Identify findings to improve cancer prevention and care delivery
• Identify the most effective treatments with the least amount of side effects
• Investigate the benefits of enhanced surgical methods and radiation therapy techniques
• Look for new indications of a previously-approved treatment
• Test the safety and effectiveness of new treatments

Clinical research trials vary by type. Prevention and screening trials focus on preventing cancer or recurrence, or detecting cancer in patients who have no symptoms of cancer. Registry trials collect uniform data to evaluate outcomes for a specific patient population. Diagnostic trials determine how to identify risk factors, while treatment trials investigate new treatments and therapies which could be more effective than existing standard of care treatments.

Every research trial is specifically selected by our research team to ensure maximum effectiveness and safety.

Clinical trial enrollment

Each study has specific guidelines, or eligibility criteria that determine who can or cannot be enrolled into the study. The criteria may include the type and stage of the cancer, age of the participant, medical history, current health status or specific genomic mutations. Study participants with similar characteristics are selected to ensure meaningful results. 

BSA Health System’s Harrington Cancer Center is proud to be a member of the Southwest Oncology Group’s (SWOG) Cancer Research Network. This network is part of the nation’s largest publicly-funded cancer research network and a major part of the cancer research infrastructure in the United States. SWOG’s Cancer Research Network is also a part of the National Cancer Institute’s (NCI) National Clinical Trials Network.

One SWOG study we recruit patients for is the Lung Cancer Master Protocol (Lung Map NCT). The Lung Map trial uses genomic profiling to guide your treatment approach. This investigational treatment is specifically selected to target genomic alterations that may be driving the growth of cancer cells. Cancer genomic studies are rapidly growing area of research that leads to better diagnoses and treatment strategies tailored to an individual patient’s needs.

We also partner with the City of Hope in the Clinical Cancer Genomic Community Network (CCGN) in conducting the Hereditary Cancer Research Registry. The CCGN is a large research group of over forty collaborating sites in the United States, Mexico, and South America. The goal of CCGN is to accelerate community-based, genomically-informed translational cancer prevention and control research.

BSA Harrington Cancer Center receives some of its funding for research from a Public Health Service (PHS) grant and is required to post the following policy: Notice of Financial Conflict of Interest Policy